The bill H. 4545 is a concurrent resolution introduced in the South Carolina General Assembly that allows for the consideration of additional matters after May 8, 2025, during the 2025 legislative session. Specifically, it permits the introduction, receipt, and consideration of H. 4262, which pertains to the restriction, regulation, or prohibition of mRNA gene therapies. This resolution outlines that the General Assembly may engage in various legislative actions related to this matter, including concurrence, nonconcurrence, and the appointment of conferees, as well as the receipt and disposition of conference reports and any applicable vetoes.

The resolution emphasizes that these actions can take place prior to the sine die adjournment of the session, thereby ensuring that the proposed legislation regarding mRNA gene therapies can be addressed in a timely manner. This addition to the legislative agenda reflects the General Assembly's intent to prioritize discussions and decisions surrounding the regulation of mRNA therapies within the specified timeframe.